Nemaura Medical Inc.
NMRD · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6,329 | $9,103 | $26,735 | $22,266 |
| - Cash | $137 | $1,378 | $4,010 | $10,105 |
| + Debt | $19,643 | $20,912 | $17,087 | $20,030 |
| Enterprise Value | $25,835 | $28,637 | $39,812 | $32,191 |
| Revenue | $0 | $0 | $0 | -$1,553 |
| % Growth | – | – | 100% | – |
| Gross Profit | -$80 | $0 | $0 | -$4,585 |
| % Margin | – | – | – | 295.2% |
| EBITDA | -$155 | -$247 | -$1,848 | -$2,247 |
| % Margin | – | – | – | 144.7% |
| Net Income | -$2,161 | -$1,203 | -$2,603 | -$328 |
| % Margin | – | – | – | 21.1% |
| EPS Diluted | -0.075 | -0.042 | -0.09 | -0.013 |
| % Growth | -79.8% | 53.8% | -582.6% | – |
| Operating Cash Flow | -$1,480 | -$3,203 | -$2,521 | -$2,362 |
| Capital Expenditures | -$10 | -$37 | -$29 | -$100 |
| Free Cash Flow | -$1,490 | -$3,240 | -$2,551 | -$2,462 |